学术资讯

Wachtell K， Hornestam B， Lehto M， Slotwiner DJ， Gerdts E， Olsen MH， Aurup P， Dahlof B， Ibsen H， Julius S， Kjeldsen SE， Lindholm LH， Nieminen MS， Rokkedal J， Devereux RB. Department of Me..

浏览:765次 评论:0条

相关链接：Treating to New Targets(TNT) Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease 阿托伐他汀强化降脂治疗稳定型冠心病 已有文献证实降低低密度脂蛋白 (LDL)胆固醇水..

浏览:868次 评论:0条

New Eng J Med.2005; Early release Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease John C. LaRosa， et al.Background ：Previous trials have demonstrated that lowering..

浏览:884次 评论:0条

当前位置：循环首页正文Treating to New Targets(TNT)Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease作者:国际循环网   日期:2005/3/28 0:00:00国际循环网版权所有，谢绝任..

浏览:725次 评论:0条

抗高血压药物对血压正常的冠心病患者心血官事件的影响 CAMELOT研究：一项随机对照临床试验 相关链接：Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal B..

浏览:744次 评论:0条

The FIELD study investigators* SummaryBackground： Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease， partly owing to dyslipidaemia， which can be amenable to fib..

浏览:1098次 评论:0条

Context Evidence suggests that more intensive lowering of low-density lipoprotein cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable coronary artery disease..

浏览:887次 评论:0条

Linda Brookes， MSc Presenters: Lisheng Liu， MD and Yuqing Zhang， MD (Fu Wai Hospital， CAMS & PUMC， Beijing， China) and Alberto Zanchetti， MD (Centro Interuniversitario di Fisiologia Clinica e I..

浏览:1031次 评论:0条

K A A Fox， P A Poole-Wilson， R A Henderson， T C Clayton， D A Chamberlain， T R D Shaw， D J Wheatley， S J Pocock， for the Randomized Intervention Trial of unstable Angina (RITA) investigators*Su..

浏览:911次 评论:0条

当前位置：循环首页正文Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a realworld setting: randomised Basel Stent Kosten Effektivitäts Trial..

浏览:737次 评论:0条

Context The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted.Objective: To determine if clopidogrel pret..

浏览:960次 评论:0条

Background—In patients with chronic heart failure (CHF)， a β-blocker is generally added to a regimen containing an angiotensin-converting-enzyme (ACE) inhibitor. It is unknown whether β-blockade a..

浏览:840次 评论:0条

OASIS-5/MICHELANGELO研究的结果支持磺达肝素用于急性冠脉综合征患者心肌梗死、顽固性缺血和死亡的预防。 这些研究结果在欧洲心脏病学会2005年会上公布，结果显示，这种合成的因子(F)Xa抑制剂在事件发生后9天内预防..

浏览:700次 评论:0条

BACKGROUND: Several recent clinical trials have demonstrated that angiotensin II receptor blockers (ARBs) have cardiovascular as well as renal protective effects. Asian patients including Japanese wer..

浏览:894次 评论:0条

Department of Cardiology， Ullevaal University Hospital， Oslo， Norway.The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study reported that a losartan-based antihypertensive re..

浏览:772次 评论:0条